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Abstract
Background: Interaction with the surrounding mesenchyme is necessary for development of
endodermal organs, and Fibroblast growth factors have recently emerged as mesenchymal-
expressed morphogens that direct endodermal morphogenesis. The fibroblast growth factor 10
(Fgf10) null mouse is characterized by the absence of lung bud development. Previous studies have
shown that this requirement for Fgf10 is due in part to its role as a chemotactic factor during
branching morphogenesis. In other endodermal organs Fgf10 also plays a role in regulating
differentiation.
Results: Through gain-of-function analysis, we here find that FGF10 inhibits differentiation of the
lung epithelium and promotes distalization of the embryonic lung. Ectopic expression of FGF10 in
the lung epithelium caused impaired lung development and perinatal lethality in a transgenic mouse
model. Lung lobes were enlarged due to increased interlobular distance and hyperplasia of the
airway epithelium. Differentiation of bronchial and alveolar cell lineages was inhibited. The
transgenic epithelium consisted predominantly of proliferating progenitor-like cells expressing Pro-
surfactant protein C, TTF1, PEA3 and Clusterin similarly to immature distal tip cells. Strikingly,
goblet cells developed within this arrested epithelium leading to goblet cell hyperplasia.
Conclusion: We conclude that FGF10 inhibits terminal differentiation in the embryonic lung and
maintains the distal epithelium, and that excessive levels of FGF10 leads to metaplastic
differentiation of goblet cells similar to that seen in chronic inflammatory diseases.
Background
The lung forms as two evaginations from the ventral
foregut at E9.5, a few days after the initial anterior to pos-
terior specification of the uniform gut tube takes place.
Sequential branching of the epithelium forms an intricate
tree of airways with a distinct axis of proximal to distal dif-
ferentiation, and a coordinated formation of blood ves-
sels at the distal end. An understanding of the budding
process that leads to epithelial branching is quite
advanced. Organ culture experiments have shown that
branching morphogenesis depends on the presence of
lung mesenchyme, which induces branching in tracheal
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fibroblast growth factor 10 (FGF10) can substitute for
mesenchyme [2]. The importance of FGF10 for lung
development is demonstrated by the fact that Fgf10 null
mice die at birth due to numerous defects, one of them
being the absence of lung buds [3,4]. Using lung explant
culture Bellusci et al and Park et al demonstrated that
FGF10 acts as a chemoattractant for the epithelium in
lung buds in vitro [2,5]. Fgf10 expression studies suggest
that FGF10-signaling plays an iterative role during lung
branching morphogenesis in vivo, as Fgf10 is expressed in
a dynamic pattern at the tip of each forming bud [2].
Although it is still unknown precisely how this Fgf10
expression pattern is controlled, factors that regulate Fgf10
expression in the lung include Fgf9 [6], Tgf-beta [7], Shh
[2] and Bmp4 [8], and interplay between the budding epi-
thelium (expressing SHH and BMP4) and the mesen-
chyme causes a rapid downregulation of Fgf10 as soon as
budding is initiated.
In vivo studies of the mechanism by which Fgf10 regulates
development of the lung are limited, but a study employ-
ing transgenic overexpression of Fgf10 by promoter ele-
ments from Clara cell secretory protein (Ccsp) or
surfactant protein C (SftpC) genes demonstrated a pro-
nounced prenatal and postnatal effect of Fgf10 overex-
pression. Transgenic expression could be detected starting
from E15.5 after embryonic induction and resulted in per-
turbed branching morphogenesis and formation of ade-
nomatous malformations in E17.5 lungs, demonstrating
that localized dynamic expression is the key to proper
branching. Postnatal overexpression of Fgf10 led to tumor
formation and differentiation of epithelial tumor cells
into a distal type II alveolar cell like phenotype. Affected
areas regressed into proximal cell types upon FGF10 ces-
sation indicating that the differentiated distal cells in this
transgenic setting required ongoing FGF10 signaling to be
maintained [9]. This result indicates that Fgf10 may play a
role in selectively regulating differentiation of the two dif-
ferent pulmonary cell lineages; the proximal conducting
airways (bronchi and bronchioles) and the distal respira-
tory airways (alveolar epithelium). The bronchial epithe-
lium contains Clara cells, ciliated cells and
neuroendocrine cells, while the alveolar epithelium con-
sists of type I and type II alveolar cells. Since most of these
cell types are specified already before birth, and ectopic
FGF10 has the potential to balance cell types in favor of
distal cells postnatally, it is possible that Fgf10 plays a role
in this prenatal specification, although this question has
not yet been addressed.
FGF10 has been shown to regulate prenatal differentia-
tion in other endodermal organs and act as a progenitor
maintenance factor. In the pancreas, Fgf10 null mice are
depleted of progenitor cells leading to arrest of growth
and differentiation of the epithelium [10], while overex-
pression causes expansion of progenitor cells and attenu-
ation of differentiation [11,12]. A similar function is seen
in the gastrointestinal tract, as Fgf10 null mice exhibit a
decrease in dividing progenitor cells [13], and ectopic
overexpression leads to attenuation of differentiation in a
lineage specific manner [14].
The apparent dichotomy of an established role of FGF10
as a chemoattractant in the lung versus a progenitor main-
tenance factor in the gastrointestinal organs might be
rooted in lack of available information due to the dra-
matic early phenotype in the lungs of Fgf10 null mice.
Indeed, a recent paper has demonstrated that dosage of
FGF10 in the lungs is critical for progenitor cell amplifica-
tion. Hypomorphic lungs exhibit severe hypoplasia most
likely due to insufficient progenitor cell maintenance and
reduced vascular development [15].
During the course of our analyses of the role of Fgf10 on
more posterior endoderm (stomach, pancreas and gut),
based on a model of ectopic expression of Fgf10 using the
supposedly pancreas/duodenal/gastric specific Pdx1 (Pan-
creatic and Duodenal homeobox 1) promoter element,
we surprisingly detected a dramatic effect on lung devel-
opment. The transgenic model allowed us to address the
hypothesis that Fgf10 controls differentiation in the
embryonic lung epithelium and functions in lung progen-
itor maintenance. We here demonstrate that the endog-
enous PDX1 protein is expressed in developing lung at
reduced levels compared to the previously described
expression in posterior stomach, pancreas and anterior
duodenum [14,16], and we find elevated level of Fgf10
mRNA and protein in lungs of the pPdx1-Fgf10 model
from E14.5. We observe effects on multiple aspects of lung
development upon ectopic presence of Fgf10 within the
developing lung epithelium: Our studies confirm that epi-
thelial branching is impaired in Fgf10 overexpressing lung
lobes [9]. Additional effects in the embryonic lung
include increased cell proliferation, distalization of the
epithelium, attenuation of terminal differentiation, and
goblet cell metaplasia. Our work using a gain-of-function
approach suggests that the tight control of Fgf10 expres-
sion observed in the lung is important in controlling the
balance between proliferation and differentiation as well
as cell lineage determination.
Results
FGF10FLAG is expressed in lung lobes of pPdx1-Fgf10FLAG 
mice
Transient transgenic mice expressing a Flag-tagged version
of mouse Fgf10 under the Pdx1 promoter elements were
obtained by oocyte injection as previously described [11].
Although this Pdx1 promoter is thought to be specific to
the pancreas, duodenum and posterior stomach, wePage 2 of 15
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mately half of the transient transgenic (TG) mice, causing
perinatal lethality. Initial assessment of pPdx1-Fgf10FLAG
embryos with malformed lungs revealed enlargement of
one or more lung lobes, and an increase in the distance
between terminal branches (Fig 1A–C). The phenotype
varied between individual mice; in two of the transgenic
mice analyzed by histochemistry the entire lung was aber-
rantly formed, while the other two embryos had abnor-
mal formation of only one of the right lobes or the entire
left lobe. Immunohistochemistry for FGF10, using an
antibody that only detects high amounts of protein, as
well as an antibody for the Flag-tag demonstrated that epi-
thelial cells in these lung lobes contained transgenic
FGF10, while the normal lobes did not (Fig 1D and 1E–F).
Some cells displayed abundant FGF10 expression in the
entire cytoplasm (Fig 1F arrow), suggesting that these cells
synthesize FGF10, while the majority of cells only stained
for FGF10 in the cell membrane (Fig 1F arrowhead). In
order to validate the production of transgenic FGF10 in
Expression of pPdx1-Fgf10FLAGFigure 1
Expression of pPdx1-Fgf10FLAG. A: Comparison of normal lung, left, and transgenic, right at E18.5. The transgenic lungs are 
larger, and exhibit an enlarged branching pattern, with increased lobular distance. B: higher magnification of normal lung, show-
ing the regularly spaced terminal branches, with only minor grooves between lobules. C: transgenic lung at similar magnifica-
tion, showing enlarged grooves between terminal branches, where individual lobules are covered with a significantly increased 
mesenchymal tissue layer. D-J: Lung Expression of pPdx1-Fgf10FLAG. D: FGF10 staining on E18.5 TG embryo showing the lobe 
specific expression of the transgene in this embryo. E: FLAG staining on E18.5 WT and F: TG. Arrow in F indicates a cell with 
high cytoplasmic FLAG staining while the arrowhead indicates a cell with only membrane staining. G: 26 cycle MPX RT-PCR of 
E14.5 and E18.5 lung (unable to detect Fgf10 in lung epithelium of E12.5) using primers for Fgf10 and G6pd-2 (Glucose-6-phos-
phate dehydrogenase gene). H-J: Fgf10 ISH on TG lung and WT littermate, arrows point to Fgf10 positive epithelial cells. H-I: 
E18.5 WT (H) and TG (I). J: E14.5 TG.Page 3 of 15
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Fgf10 and low cycle multiplex (MPX) RT-PCR for
Fgf10FLAG mRNA using G6pd-2 as a control. MPX RT-PCR
for the transgenic construct showed that Fgf10FLAG mRNA
was detectable in the TG lung (Fig 1G). In situ hybridiza-
tion with a short detection time showed Fgf10 in the epi-
thelium of the transgenic lung lobes of E14.5 and E18.5
embryos (Fig 1H–J), confirming ectopic presence of Fgf10.
The highest Fgf10 mRNA expression was confined to
small clusters of cells in the E18.5 embryos (Fig 1I insert)
and to isolated cells at E14.5 (Fig 1J). Variation in expres-
sion of Fgf10 in pancreas and stomach due to mosaicism
in these embryos has been reported before [11,14], in all
cases, FGF10 protein expression was widespread due to
the secreted nature of the protein (Fig 1D).
The observed phenotype and the expression of Fgf10FLAG
mRNA and protein in the transgenic lung demonstrate
that the Pdx1 promoter construct must be active in this tis-
sue. This was surprising given the previously reported very
accurate replication of endogenous Pdx1 expression con-
ferred by the construct in the pancreas, duodenum and
posterior stomach [11,14]. As the Pdx1 promoter frag-
ment used is limited to app. 4.5 kb upstream regulatory
sequence, lung expression may be explained by absence of
regulatory elements involved in repression of the Pdx1
promoter outside the distal foregut domain. However, it
was also possible that Pdx1 is normally expressed in lung
at a low level and would therefore not have been previ-
ously detected. We tested this latter hypothesis by per-
forming an analysis of PDX1 expression throughout
embryonic development. Our results revealed that PDX1
protein is present in the early lung buds at E12.5, albeit at
a very low level compared to pancreatic and duodenal
expression (Fig 2A–B). We were unable to detect any
PDX1 expression in E14.5 (results not shown) and E18.5
(Fig 2F) wildtype lungs, but in transgene expressing lung
lobes significant PDX1 protein expression was main-
PDX1 expressionFigure 2
PDX1 expression. A-B: PDX1 immunostaining on E12.5 wildtype embryos. A: Strong PDX1 expression in pancreas. B: Much 
weaker, but still detectable nuclear PDX1 expression in the lung bud. A': Magnification from A. B': Magnification from B. C-H: 
PDX1 immunostaining on E18.5 TG and WT lung. C: PDX1 and E-cadherin IHC demonstrates that PDX1 is upregulated in the 
TG lung. D: FGF10 IHC on TG lung. E: Merge of PDX1 and FGF10 IHC demonstrates that not all PDX1 positive cells express 
cytoplasmic FGF10 (arrow), but all FGF10 producing cells express PDX1(arrowhead). F: PDX1 and E-cadherin IHC on WT 
lung. G: FGF10 IHC on WT lung. H: merge of F and G.
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exhibited the transgenic phenotype in the entire lobe,
likely attributed to the secreted nature of FGF10. Not all
PDX1 expressing cells displayed high levels of cytoplasmic
staining for FGF10, but all FGF10 secreting cells were pos-
itive for PDX1 (Fig 2E). These observations argue that
FGF10 is capable of autocrine maintenance of cells with
Pdx1 expression, otherwise lost during development.
Disruption of branching morphogenesis and bronchiole 
formation
Histological examination of transgenic E18.5 lungs
revealed that the increased size observed was due to
hyperplastic growth as well as formation of large empty
lumens surrounded by a mesenchymal layer (Fig 3B and
3C). Branching morphogenesis was disrupted leading to
formation of dense areas of tissue composed of mesen-
chyme and epithelium, somewhat resembling the pseu-
doglandular stage (E9.5–15.2). Proximal bronchi were
formed to some degree, but terminal bronchioles were
absent (compare figure 3D and 3E). These results support
previous findings [9] that Fgf10 overexpression in the lung
is lethal at birth due to pulmonary defects including per-
turbed branching morphogenesis.
In embryos with only one malformed lobe, the surround-
ing lobes appeared normal (Fig 3C). Throughout this
study we show data obtained from one embryo with a sin-
gle malformed lobe (represented in figure 3C) as well as
data obtained from one transgenic embryo with the entire
lung malformed and one wildtype littermate embryo
(represented in figures 3B and 3A), as each was represent-
ative for their phenotype. As we cannot exclude that
wildtype-like lobes in the transgenic embryos have been
exposed to ectopic FGF10 early in development, the TG
lung lobes displaying wildtype morphology are labeled
"WT" on the figures also containing TG lung lobes with a
pronounced phenotype.
Lung development is highly abnormal in transgenic embryosFigure 3
Lung development is highly abnormal in transgenic embryos. Hematoxylin and Eosin staining. A: Wildtype E18.5 lung 
lobe. B: Transgenic E18.5 lung lobe. Transgenic embryos exhibited highly abnormal lung development with disruption of 
branching morhogenesis leading to formation of empty lumens and dense tissue in place of alveolar sacks. The alveolar epithe-
lium appeared undifferentiated without the typical flattening usually seen at this stage. Proximal bronchi development had 
occurred to some degree, but distal bronchioles were absent. C: One of two embryos that expressed Fgf10FLAG in a single lobe 
only. Surrounding lobes expressed no transgene and appeared normal, thus providing and excellent comparison for the trans-
genic phenotype. D: Magnification from A. E: Magnification from B. The lung lobe shown in C and the transgenic lung repre-
sented in B are shown throughout the paper, as they were representative for the phenotypes.Page 5 of 15
(page number not for citation purposes)
BMC Developmental Biology 2008, 8:2 http://www.biomedcentral.com/1471-213X/8/2FGF10 overexpression results in lung hyperplasia due to 
increased cell proliferation
The number of cells undergoing mitosis at E18.5 in the
alveolar tissue is normally negligible (Fig 4A–B and
4D–E), although the entire epithelium in the bronchi is
still positive for Proliferating Cell Nuclear Antigen
(PCNA) (results not shown). In contrast, the majority of
cells were PCNA positive throughout the transgenic lung
lobes, in mesenchyme and epithelium (Fig 4A and 4C),
demonstrating that transgenic lung lobes are still in a pro-
liferative state. Indeed, as judged from phosphorylated
Histone H3 (pHH3) staining, many cells were in M-phase
in the TG lobe, but very few in the "WT" lobe (Fig 4D–F).
These results support previous findings that FGF10 stimu-
lates pulmonary proliferation in vitro [2] and correspond
with the reduction of epithelial cell proliferation seen in
Fgf10 hypomorphic mice [15].
Increase in number of cells undergoing proliferationFigure 4
Increase in number of cells undergoing proliferation. A-C: PCNA, E-cadherin and smooth muscle actin IHC shows that 
more cells undergo mitosis in the TG lobe mesenchyme and epithelium, and that a rim of smooth muscle cells surround the 
TG lobe. A: TG lung with non Fgf10FLAG expressing lobe ("WT") and transgene expressing lobe (TG). B and C are magnified 
from A. D-F: Phospho-histone H3, E-cadherin and smooth muscle actin IHC. D: TG lung with non Fgf10FLAG expressing lobe 
("WT") and transgene expressing lobe (TG). Many cells are in M-phase in the TG lobe, but very few in the "WT" lobe. E and F 
are magnified from J.Page 6 of 15
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FGF10 is expressed in parabronchial smooth muscle pro-
genitors and mice hypomorphic for Fgf10 and mice with
a FgfR2b splicing defect exhibit a reduction in smooth
muscle cells [15,17]. We therefore proceeded to analyze
expression of smooth muscle actin by immunohisto-
chemistry. Parabronchial smooth muscle cells seemed
unaltered in those cases where proximal bronchi did
form, but unlike wildtype lungs, transgenic lungs had
developed a layer of smooth muscle actin positive cells
surrounding the perimeter of the lung lobe (Fig 4A,D and
see also Fig 6A and 6D). A few cells within this band were
actively dividing (pHH3 positive) (Fig 4D).
Attenuation of alveolar differentiation and retention of 
markers of the undifferentiated distal buds
The high number of cells still undergoing mitosis at E18.5
indicated that transgenic pulmonary cells had not differ-
entiated to the same extent as wildtype. Pro-surfactant
protein C is expressed as early as E11.5 in the murine lung
progenitor cells [18] and is also expressed by alveolar type
II cells developing before birth. This protein was expressed
in both TG and WT lungs, but was expressed in cuboidal
cells arranged in a simple epithelium in the transgenic
lobes (Fig 5A and 5D) as opposed to the rounded solitary
alveolar type II cells in WT lungs (Fig 5A and 5C). The
majority of transgenic epithelial cells were pro-surfactant
protein C positive. Analysis of expression of the receptor
for advanced glycation end-products (RAGE), a marker for
alveolar type I cells (gas exchange cells) [19,20] revealed
an almost complete absence in TG lungs (Fig 5B and 5F).
Type I alveolar cells are abundant in E18.5 wildtype lungs
and constitute a major part of the alveolar epithelium,
with type II alveolar cells occupying the corners between
type I cells (Fig 5B and 5E).
The absence of type I cells in the transgenic lobes and the
presence of pro-surfactant protein C expressing cells that
did not resemble mature type II cells, suggested that differ-
entiation was inhibited. Further characterization of the
pro-surfactant protein C expressing cells showed that
these cells were actively dividing (Fig 5G and 5H), and
that they expressed the ETS factor PEA3 (ETV4) (Fig 5J),
which is a FGFR-signaling target and a marker of distal
bud cells [21]. This transcription factor was only expressed
in a few cells in the wildtype alveolar tissue, and was not
expressed in type II cells (Fig 5I).
In order to determine if FGF10 overexpression had
resulted in arrest of pulmonary cells in a state resembling
the undifferentiated distal bud cells, as suggested by PEA
expression, we analyzed the presence of several other
markers that characterize these cells. Ttf1 (Nkx2.1)
encodes a lung-specific homeodomain factor that is
expressed from E11.5 in the lung bud epithelium and
after birth in type II cells [22]. We detected presence of
TTF1 in transgenic epithelial cells, but only in a few
peripheral wildtype cells (Fig 5K–L). Clusterin is a glyco-
protein that is associated with cell damage in adult cells
and with differentiation during development. It is
expressed transiently during branching morphogenesis in
the lung and is localized in the epithelial cells of the distal
buds [23]. Clusterin was not expressed in WT E18.5 lung,
but was expressed in transgenic epithelial cells facing the
lumen (5M-N). TTF1, clusterin and pro-surfactant protein
C were co-expressed by the transgenic epithelial cells (Fig
5R), similar to what is seen in the distal tips during the
late pseudoglandular stage (E9.5–E15.2) (Fig 5S–V and
additional file 1). The observed expansion of the expres-
sion pattern of several early distal markers indicate that
Fgf10 overexpression leads to distalization of the entire
embryonic lung, similar to what has previously been
found in postnatal lung tumors [9]. The absence of
mature distal type I and type II cells furthermore indicate
that the transgenic cells, although specified to a distal fate,
are arrested in a progenitor-like state.
Bronchi and bronchiole formation and differentiation are 
disrupted by FGF10
Initial assessment of the phenotype revealed that terminal
bronchioles were missing, while proximal bronchi devel-
opment had taken place to some degree, but had differen-
tiation of the bronchial cell lineages taken place? Analysis
for expression of uteroglobin, a Clara cell marker, revealed
that, as expected from the lack of terminal bronchiole
development, there were no Clara cells in the distal lung
(Fig 6A and 6C). Proximal bronchi development was also
perturbed as the number of cells expressing uteroglobin
was reduced compared to wildtype (Fig 6D,E, arrow in E
insert points to a gap in expression). Sox2 is expressed in
ciliated cells of wildtype trachea and bronchi ([24] and
6F), and expression of this marker was greatly reduced by
FGF10. Ciliated cells were found in the most proximal
areas, but were similarly reduced as the Clara cells (data
not shown), while they were almost absent from more
distal areas (Fig 6G). Only a few scattered ciliated cells
remained in the distal epithelium suggesting that bronchi-
ole development was aborted (Fig 6G). Interestingly, one
particular bronchial lineage descendant was capable of
forming. CGRP expressing pulmonary neuroendocrine
cells (PNECs) were still present in the transgenic lung
lobes. In the wildtype lung these cells were confined to
bronchi and bronchioles and appeared in small clusters
(Fig 6H), while they were scattered throughout the trans-
genic lung (Fig 6I). Our results support the assessment
that bronchiole development was terminated, as only
PNECs were present in the distal transgenic lung.Page 7 of 15
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Alveolar differentiation is attenuated and early distal bud markers upregulatedFigure 5
Alveolar differentiation is attenuated and early distal bud markers upregulated. A-B: TG lung with non FGF10FLAG 
expressing lobe ("WT") and transgene expressing lobe (TG). A: Pro-surfactant protein C IHC. B: Pro-surfactant protein C and 
RAGE IHC. C-D: High magnification from A. E-F: High magnification from B. G-H: PCNA and pro-surfactant protein C IHC. G: 
WT lung, with no PCNA positive alveolar type II cells. H: TG lung with double positive cells. I-J Pea3 and pro-surfactant protein 
C IHC. I: WT lung with no Pea3 positive alveolar type II cells. J: TG lung with several double positive cells. K-L: TTF1 IHC on 
WT (K) and TG (L) show expression mainly in TG cells. M-N: Clusterin IHC on WT (M) and TG (N) show expression only in 
TG cells facing the lumen. O-P: pro-surfactant protein C IHC on WT (O) and TG (P). Q: merge of K, M and O. R: Merge of L, 
N and P shows triple positive cells. S-V: E16.5 WT lung S: TTF1 IHC. T: Clusterin IHC. U: Pro-surfactant protein C IHC. V: 
merge of S-U demonstrates that TTF1, clusterin and p-SftpC are co-expressed in the distal bud (arrowhead in S-V and inset in 
V) at E16.5.
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Attenuation of mature lung bronchial cellsFigure 6
Attenuation of mature lung bronchial cells. IHC on E18.5 embryos. A-C: Uteroglobin, PCNA and smooth muscle actin 
IHC. Showing distal part of transgenic lung which has one Fgf10FLAG negative untransformed lobe ("WT" lobe), and one lobe 
expressing Fgf10FLAG (TG). No uteroglobin positive Clara cells are seen in the distal TG lung (A and C), while bronchioles in 
the "WT" lobe contain Clara cells (A and B). D-E: Uteroglobin, E-cadherin and smooth muscle actin IHC oriented with most 
proximal end in upper right corner. D: WT proximal lung. E: TG proximal lung. Arrow in inset points to Uteroglobin negative 
cells. F-G: SOX2 and E-cadherin IHC on distal lung. F: WT bronchiole with SOX2 positive ciliated cells. G: TG lung with a few 
scattered Sox2 positive cells. H-I: CGRP and E-cadherin IHC. H: WT bronchus with clusters of PNECs. I: TG lung with scat-
tered CGRP positive cells.
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transdifferentiation to intestinal, gastric or pancreatic 
fates
The observation that transgenic lungs lacked terminal pul-
monary cells lead to speculations of whether transdiffer-
entiation to a pancreatic, gastric or intestinal fate had
taken place, due to ectopic expression of FGF10 and
PDX1. We performed immunohistochemistry for expres-
sion of NKX6.1 (pancreas marker) and insulin, but did
not detect expression, indicating that transdifferentiation
to a pancreatic fate did not occur (see Additional files 2,
figures A-C). CDX2 is expressed throughout the intestine,
MATH1 is expressed by intestinal secretory cell lineages,
Cryptdin3 by Paneth cells and intestinal fatty acid binding
protein (Fabp2) by enterocytes. In the transgenic lungs we
could not detect CDX2 or Fabp2 expression (Additional
file 2figures D and J), and only very few Cryptdin3 or
MATH1 expressing cells (Additional file 2 figures G and D.
Insert shows positive cells in Fig G). Sox2 is expressed in
the gastric epithelium, throughout the esophagus, and is
present in the ciliated cells in the bronchi [24], but very
little expression was seen in the transgenic tissue outside
of bronchi (Fig 6F–G). Likewise, H/K-ATPase and Pep-
sinogenC, expressed by Parietal and chief cells respec-
tively, were also absent (results not shown). Trefoil factor
1 (Tff1) is normally expressed by mucous producing cells
in the stomach (Additional file 2, figure O), and is absent
from embryonic lung (Additional file 2, figure N). A few
Tff1 positive cells were found in one out of three trans-
genic mice (Additional file 2, figure M). Tff3 is expressed
in intestinal goblet cells, and although not expressed in
embryonic lung (Fig 7C), is expressed by pulmonary gob-
let cells in the tracheal submucosal glands in adult mice
[25]. Tff3 was expressed in several cells throughout the
distal epithelium in all transgenic lobes (Fig 7D). We
therefore conclude that transdifferentiation to a gut like
fate had not taken place, although limited expression of
MATH1 and Tff1 as well as high expression of Tff3 pointed
towards a possible goblet cell metaplasia.
Embryonic goblet cell metaplasia
Goblet cells are present in only few numbers in submu-
cosal glands of adult mice although more cells can form
as a response to inflammation in adult mice and humans,
and in some human lung cancers. Goblet cells react with
Dolichos Biflorus Agglutinin (DBA) [26], and detection of
rhodamine or Cy2 conjugated DBA, as well as PAS/alcian
blue histochemistry (data not shown), confirmed that
goblet cells were present in the distal epithelium of trans-
genic but not wildtype lobes (Fig 7A and 7B). No DBA
reactivity was found in bronchi or trachea. Since this gob-
let cell metaplasia had arisen in the prospective alveolar
epithelium, we performed a double immunofluorescence
analysis for DBA and pro-surfactant protein C. Similar to
WT lung, DBA and p-SftpC were not co-expressed (Fig 7F,
insert).
Increased Beta-catenin signaling and Bmp4 expression
Regulation of transcription through activation of stabi-
lized beta-catenin is necessary for differentiation of distal
airways [27], and transgenic expression of an activated
form of beta-catenin leads to goblet cell metaplasia and
expansion of alveolar type II-like cells [28]. Since goblet
cell metaplasia and expansion of surfactant Protein C
expressing cells were also observed in the pPdx1-Fgf10FLAG
model, we next tested whether the observed phenotype
could be caused partly through activation of beta-catenin
(reviewed in [29]). We analyzed for activation of beta-cat-
enin using an antibody specific for the dephosphorylated
Serine37 or Threonine41, which is an activated form [30].
Cells positive for activated beta-catenin were present
throughout the epithelium and mesenchyme in both
wildtype and transgenic lobes (Fig 8A–B), and more acti-
vated cells were present in the distal part of the wildtype
lung (data not shown), than the proximal part (Fig 8A).
The frequency of activated beta-catenin cells was higher in
the transgenic lobes, especially in the proximal lung (Fig
8B) but also in the distal lung (data not shown), suggest-
ing that Fgf10 overexpression leads to activation of beta-
catenin.
Bmp4 is expressed in the distal-most epithelial cells in
proximity to the FGF10 expressing mesenchyme, and
Bmp4 expression is upregulated in response to a FGF10
bead [8]. We therefore analyzed whether Bmp4 expression
was increased in the pPdx1-Fgf10FLAG lung. In situ hybrid-
ization revealed that Bmp4 was expressed in scattered epi-
thelial cells at E18.5 (Fig 8C), while the number of Bmp4
positive cells was increased in transgenic lungs (Fig 8D).
This result was confirmed by MPX RT-PCR, where Bmp4
but not Bmp5 expression was highly upregulated in trans-
genic lungs (Fig 8E).
These results confirm previous in vitro data and demon-
strate that Fgf10 overexpression leads to activation of beta-
catenin and upregulation of epithelial Bmp4 expression,
suggesting that these are downstream effectors of Fgf10
and could be involved in the observed phenotype. This
observation is in agreement with previous reports show-
ing that reductions in FGF-signaling leads to reduced Wnt-
signaling [31].
Discussion
Development of the lung is an intricate process whereby
coordination of branching of the epithelium and concom-
itant differentiation leads to a highly patterned organ.
Embryonic lung formation by branching morphogenesis
depends on chemotactic attraction by FGF10 secreted
from the mesenchyme [2-4]. This is however not the onlyPage 10 of 15
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evidence that in addition to controlling branching mor-
phogenesis, FGF10 maintains the undifferentiated state of
the progenitor like cells of the distal buds, hereby coordi-
nating the two processes.
We show here that PDX1 is expressed by the epithelium of
embryonic lung at E12.5, and we employ a Pdx1 promoter
construct to drive Fgf10 expression from this time
onwards, as ectopic FGF10 expression presumably allows
for maintenance of PDX1 expression. Notwithstanding a
possible physiological role of Pdx1 in lung development
which is not investigated here, the Pdx1 promoter driven
expression of Fgf10 is sufficient to elicit a significant effect
on lung development. We confirm previous results show-
ing that overexpression of Fgf10 in the embryonic lung
epithelium is highly disruptive for branching morphogen-
esis [9], and demonstrate that the observed enlargement
of the lung is due to hyperplastic growth and formation of
large internal cavities. We conclude that Fgf10 overexpres-
sion has a mitogenic effect in vivo similar to what has
been previously demonstrated in vitro [2], corresponding
with the reduction of epithelial cell proliferation seen in
Fgf10 hypomorphic mice [15]. Transgenic lungs were cov-
ered by a dense layer of smooth muscle, also supporting
previous findings by Mailleux et al [17] that FGF10 is
required for entry of mesenchymal cells into the parab-
ronchial smooth muscle cell lineage.
Goblet cell metaplasia in the alveolar epitheliumFigure 7
Goblet cell metaplasia in the alveolar epithelium. A-B: IHC with Rhodamine-conjugated Dolichos Biflorus Agglutinin (DBA) and 
Beta-catenin. Goblet cells detected by their DBA reactivity were present in the alveolar epithelium of the transgenic mice (B), while no 
goblet cells were detected anywhere in the wildtype lungs (A). C-D: ISH using a Trefoil factor 3 probe. No Tff3 was detected in wildtype 
lung. Goblet cells in the transgenic lung were positive (D). E-F: IHC for pro-Surfactant protein C and fluorescein conjugated Dolichos 
Biflorus Agglutinin (DBA). Goblet cells did not co-express pro-Surfactant protein C.Page 11 of 15
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posterior endoderm [11,12,14] and the postnatal effect of
FGF10 overexpression on differentiation of tumors [9],
we wished to explore the hypothesis that Fgf10 functions
in embryonic lung progenitor maintenance. At E18.5,
transgenic pulmonary cells were phenotypically similar to
wildtype cells before completion of the canalicular stage
(E16.6–17.4). The majority of the transgenic airway cells
remained undifferentiated and mitotic at a time when
cells outside of the bronchial epithelium normally cease
active proliferation and terminal lung cells differentiate.
Markers of early distal cells such as TTF1, the FGFR target
PEA3 and Clusterin were co-expressed with pro-Surfactant
protein C, while markers of differentiated alveolar type I
cells and bronchial cells were largely absent. Pro-sur-
factant protein C is expressed both early in development
and in alveolar type II cells, but mature alveolar type II
cells do not co-express TTF1 and Clusterin or PEA3. In
contrast, these markers were co-expressed in the trans-
genic lung and in wildtype E16.5 distal bud cells before
differentiation. These results demonstrate that ectopic
overexpression of Fgf10 results in attenuation of differen-
tiation and promotion of a progenitor-like distal cell type.
An embryonic progenitor maintenance program such as
this is necessary for sufficient expansion of the progenitor
pool before differentiation, but can contribute to onco-
genesis if reinstated during postnatal life. The previous
finding that postnatal Fgf10 overexpression induces lung
tumors with high expression of TTF1 and SftpC thus cor-
responds with our findings that FGF10 maintains the dis-
tal progenitor-like cells during early embryonic
development.
Consistent with the published FGF10 induction of Bmp4
expression in lung buds in vitro [8], we observed upregu-
lation of Bmp4 expression in the TG lung. It is likely that
part of the observed effects are caused by the altered
expression of Bmp4, as BMP signaling has been shown to
be necessary for the morphologically correct development
of lung buds [32]. However, BMP4 has an anti-prolifera-
tive effect in the lung, suggesting that the proliferating
progenitor-like cells seen in the pPdx1-Fgf10FLAG lung are
Beta-catenin activation and upregulation of BMP4 expressionFigure 8
Beta-catenin activation and upregulation of BMP4 expression. A-B: IHC using an antibody that is specific for activated 
beta-catenin dephosphorylated on Ser37 or Thr4, and an antibody that recognizes only membrane bound beta-catenin. Coun-
terstained with Hoechst (hst). A: Wildtype alveolar lung contains scattered cells with activated beta-catenin. B: Beta-catenin is 
activated in more cells in the transgenic lung. A': magnification from A. B' Magnification from B. In both WT and TG, cells are 
double positive for activated and membrane-bound beta-catenin, implying that cells retain membrane-bound beta-catenin even 
when activated. C-D: ISH using a probe for Bmp4. Bmp4 was expressed in both wildtype (C) and transgenic (D) distal lung epi-
thelium, but transgenic expression was much more widespread. Part of the right atrium (Bmp4 negative) is seen to the right 
hand side of the TG lung lobe in D. E: Multiplex-RTPCR of E14.5 wildtype and transgenic lung using primers for G6pd-2 (Glu-
cose-6-phosphate dehydrogenase gene), Bmp4 and Bmp5 shows upregulation of Bmp4 mRNA.Page 12 of 15
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cate that this mechanism works through activation of
beta-catenin. In previous studies, ectopic expression of an
activated form of beta-catenin caused distalization of the
proximal airways and goblet cell hyperplasia [28], while
ectopic expression of a beta-catenin-Lef1 fusion protein
lead to expansion of progenitor cells and intestinal meta-
plasia of the lung epithelium [33]. The observed differ-
ence between the two studies is probably due to binding
specificity of Lef1 as opposed to TCF factors. We observe a
similar expansion of distal-like progenitor cells, indicat-
ing that activation of beta-catenin may be the main mech-
anism through which FGF10 maintains undifferentiated
distal cells. We conclude that the arrested lung phenotype
resembles that of the undifferentiated distal lung buds,
possibly caused by an increase in Bmp4 expression and
beta-catenin activation, and appears incapable of normal
differentiation under conditions of high FGF10 expres-
sion. Consequently, FGF10 elicits lung epithelial progen-
itor arrest, in a comparable manner to that observed in
pancreas [11], stomach [14] and duodenum (Nyeng et al.
Manuscript submitted), indicating a conserved role of
FGF10 in the endoderm.
In the light of the attenuated lung program, it was possible
that transdifferentiation of the lung to a pancreatic, gastric
or intestinal fate had occurred as a result of ectopic FGF10
and PDX1 expression. Respecification of endodermal cells
has been noted in several cases. Overexpression of Pdx1 in
the liver of Xenopus tadpoles leads to transdifferentiation
into pancreas [34], and forced expression of Ptf1a and
Pdx1 is capable of inducing a pancreatic fate in more ante-
rior endoderm, including stomach, but not lung [35]. We
found no evidence of transdifferentiation using pancreatic
markers whereas early lung markers such as TTF1 and pro-
surfactant protein C were preserved. There was also no evi-
dence of conversion to a gastric fate. Transdifferentiation
of lung epithelium to an intestine-like fate as seen in the
beta-catenin-Lef1 fusion protein model resulted in expres-
sion of Paneth cell markers, Math1 and Cdx1 among other
intestinal genes[33]. Although Fgf10 overexpression leads
to dephosphorylation and activation of beta-catenin in
our model, we did not find evidence to suggest a major
transformation towards an intestinal fate. Although we
did observe a few MATH1 expressing cells in the lung, and
also several goblet cells, which derive from MATH1
expressing cells, the absence of CDX2 and Fabp2 argues
against major posteriorization of the lung to an intestinal
phenotype.
Our observation that goblet cells were present in the pro-
spective alveolar epithelium is indicative of goblet cell
metaplasia. Increased presence of goblet cells in the lung
is often observed during adult lung pathogenesis such as
asthma, COPD and cystic fibrosis. Adult goblet cell hyper-
plasia has been associated with activation of EGFR result-
ing in signaling through the RAS-MAP-kinase pathway
leading to an increase in expression of genes involved in
goblet cell formation (reviewed in [36,37]). It is possible
that increased FGFR signaling upstream of the MAP-
kinase pathway may trigger the same mechanistic path-
way, consistent with our observation of upregulation of
PEA3, a target of the MAP-kinase pathway. An alternate
mechanism could be that the FGF10 mediated activation
of beta-catenin seen in our model lead to goblet cell meta-
plasia, as expression of an activated form of beta-catenin
results in goblet cell hyperplasia of the bronchial epithe-
lium through this mechanism [28,38] Goblet cell meta-
plasia has been shown to originate from Clara cells
(reviewed in [37]) in adult lung pathogenesis. It seems
highly unlikely that goblet cells originate from Clara cells
in our model, as we did not observe any goblet cells near
the bronchial epithelium. Alveolar type II cells function as
a progenitor cell for the alveolar cells [39], raising the pos-
sibility that metaplastic goblet cells could have differenti-
ated from alveolar type II progenitor cells. We cannot
exclude this possibility, although no SftpC and DBA dou-
ble-positive cells were found. We conclude that Fgf10
overexpression leads to embryonic goblet cell metaplasia
of the prospective alveolar epithelium, but not conversion
to a more posterior endodermal fate. These results dem-
onstrate that, even though Fgf10 overexpression perturbs
lung morphology and attenuates the lung differentiation
program, the lung still retains pulmonary identity.
Conclusion
FGF10 is normally expressed in proximity to budding epi-
thelium, where it directs branching morphogenesis spa-
tially [2,5]. After a certain degree of completion of the
branching process, differentiation occurs into either prox-
imal or distal lung regions, as a response to intra-organ
patterning set up early in lung development. Our results
here demonstrate that overexpression of Fgf10 during
embryonic development leads to attenuation of differen-
tiation, distalization of the epithelium and goblet cell
hyperplasia. These results suggest that a single molecule,
FGF10, is intricately involved in coordinating pulmonary
branching morphogenesis and cellular differentiation. In
turn, this argues for a possible coordinate regulation of
these two processes, which perhaps therefore should not
be viewed as separate mechanisms.
Methods
Transgenic mice
pPdx1-Fgf10FLAG construction and derivation of trans-
genic embryos by oocyte injection was performed as
described in [11], and approved by the UCHSC Animal
Care and Use Committee. Day of oocyte injection was
counted as day 0.5. A total of 7 E18.5 and 6 E14.5 tran-
sient transgenic embryos with a lung phenotype and theirPage 13 of 15
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guts from four E18.5 embryos and three E14.5 embryos
were fixed in 4% PFA overnight, embedded for freeze sec-
tioning in OCT medium, and sectioned at 6 μm. The
remaining embryos were dissected and duodenal RNA
was extracted using Trizol. For studies of wildtype E16.5
lung, CD1 mice were mated and the pregnant dam sacri-
ficed on E16.5 (Noon of day of plug was counted as day
0.5).
Multiplex RT-PCR analysis
cDNA was synthesized from 1 μg of purified RNA and
analyzed by semi-quantitative radioactive multiplex RT-
PCR (MPX RT-PCR) previously described by [40]. A
primer set for glucose-6-phosphate dehydrogenase (G6pd-
2) (GACCTGCAGAGCTCCAATCAAC and CACGAC CCT-
CAGTACCAAAGGG) was included in all PCR reactions as
an internal control for normalization, and the PCR reac-
tions were run for 26 cycles. A primer pair for the beta-
globin tail of the pPdx1-Fgf10FLAG construct (GTTGCCGT-
CAAAGCCATCAAC and CTACTTGTCATCGTCGTCCTT)
was used for genotyping and expression analysis. Primers
for Bmp4 (CTGAGTATCTGGTCTCCGTCC and AAGGCT-
CAGAGAAGCTGCGGC) and Bmp5 (GCAAAAGGAG-
GCTTGGGAGA and TCGCTAGCCATGGCATTGTA) were
used for expression analysis.
Histology
Immunohistochemistry and in situ hybridization were
performed on 6 μm frozen tissue slides fixed in 4% para-
formaldehyde as described in [11]. Antigen retrieval was
performed for 10 minutes in microwave oven in 0.01 M
citrate buffer pH6. Antibodies used in this study include:
goat-anti-Fgf10 (1:200, Abcam, Cambridge, UK), rabbit-
anti-FLAG-HRP (1:1000, Sigma, St. Louis, MO, USA) with
TSA, goat-anti-PDX1 (1:2000, CV Wright, Nashville, TN,
USA), rat-anti-E-Cadherin (1:200, Zymed/Invitrogen,
Carlsbad, CA, USA), mouse-anti-smooth muscle actin
(1:500, 1A4, DAKO, Denmark), rabbit-anti-PCNA (1:150,
Santa Cruz BT, Santa Cruz, CA, USA), rabbit-anti-phos-
pho-Histone-H3 (1:100, Upstate, VA, USA), mouse-anti-
clusterin (1:50, R & D systems, Minneapolis, MN, USA),
rabbit-anti-pro-surfactant protein C (1:100, Upstate,
Charlottesville, VA, USA), rabbit-a-Uteroglobin (1:1600,
Abcam, Cambridge, UK), rabbit-a-RAGE (1:800, Abcam,
Cambridge, UK), rabbit-a-beta-catenin (1:200, Neomark-
ers, Fremont, CA, USA), rabbit-a-PEA3 (1:200, Santa Cruz
BT, Santa Cruz, CA, USA) mouse-a-TTF1 (1:800, Affinity
Bioreagents, Golden, CO, USA), rabbit-a-SOX2 (1:1000
TSA, Abcam, Cambridge, UK), rabbit-a-CGRP (1:10,000,
Sigma, St. Louis, MO, USA) and Rabbit-a-ABC (Active
beta-catenin, 1:1000 TSA, Upstate, Charlottesville, VA,
USA). TSA signifies whether a tyramide signal amplifica-
tion kit (Perkin Elmer, CA, USA) was used for detection.
Mature goblet cells were detected by an overnight staining
using rhodamine or fluorescein conjugated Dolichos
Biflorus Agglutinin (DBA) (Vector Laboratories).
In situ probes where synthesized from mouse Fgf10 and
Bmp4 previously isolated in our lab and cloned in pCR4
plasmids and Tff1, Tff3, Cryptdin3 and Fabp2 plasmids
(Open Biosystems, Huntsville, AL, USA).
Harris hematoxylin and eosin Y staining was carried out
according to standard protocols.
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